Vantage Urologic Institute

About Us

A Message From Dr. Locke

After twenty-two years as founder and director of the Urology Center of Florida, I was privileged with the opportunity to establish the Vantage Urologic Institute.

The creation of the Vantage Urologic Institute was inspired by the veritable explosion of new scientific discoveries that are fueling hopes for better treatments and quicker cures as well as emerging trends in “personalized medicine” with focus on tailoring urologic treatment and disease management strategies to the individual characteristics of each patient.

Personalized urologic healthcare at the Vantage Urologic Institute is envisioned as healthcare that will utilize patient-specific characteristics, including age, gender, height/weight, diet, environment, as well as molecular markers and other gene-based information to understand each person’s individual requirements for the maintenance of their health, early diagnosis of disease, prognosis, and targeted therapy tailored to their individual uniqueness. Increasingly, it will give us the ability to move beyond practicing urology that works well for the majority of people the majority of the time, to practicing urology that is individualized for specific patients.

The new Vantage Urologic Institute is located at the West Marion Medical Plaza on the campus of West Marion Community Hospital. The Institute occupies space on the first level of the plaza accommodating both clinical and research activities. The Institute has been carefully designed to provide patients with care for all urological disorders, to optimize every aspect of the patient experience, and to create an environment in which urologists and clinicians from different disciplines can work together synergistically in patient care, education and research.

Together with my fellow colleagues and staff the Institute provides comprehensive and compassionate care using a multidisciplinary approach to diagnosis and treatment of patients with genitourinary disorders and cancer.

The Vantage Urologic Institute encompasses a wide variety of specialized care for diseases of the male and female urinary tract and the male reproductive organs. Featured services within the Institute include:

  • A program of informed and shared decision making for risk assessment, prevention, and early detection of prostate cancer that minimizes over detection and subsequent over treatment of potentially insignificant cancer; 
  • A urologic oncology program that focuses on the diagnosis, disease stratification and tailored management strategies for prostate and bladder cancer with the goal of oncologic control while preservation of normal function;

  • A structured active surveillance (delayed intervention) program for patients with low risk prostate cancer who are concerned about the risks associated with over-treatment of indolent disease;
  • A male sexual health program for the evaluation of erectile dysfunction and testosterone deficiency;

  • A program for restoration of urinary control particularly directed to males with incontinence;

  • A program for treatment of prostatic outflow obstruction through behavioral therapy, pharmaceutical management, and minimally invasive techniques including laser photoselective vaporization of the prostate (PVP) and plasma vaporization of the prostate using the Olympus TURis system; and

  • A program for minimally invasive surgery, including robot-assted laparoscopic surgery for the management of prostate, kidney and bladder cancer.  

Patients choosing to have their care at the Vantage Urologic Institute can be certain they will receive prompt evaluation by our experienced and highly trained staff.  Each patient will undergo a complete assessment, diagnostic evaluation and have a comprehensive treatment plan initiated at the conclusion of their initial visit.  A detailed letter will be sent to each patient’s primary and/or referring physician(s) describing the patient’s encounter at the Institute.

We are dedicated to delivering the highest level of care to our patients throughout the course of their evaluation and treatment. We believe a patient’s primary and/or referring physician, is an integral part of that care.  Thus we are committed to keeping them informed about their patient’s treatment and providing them up-to-date information on a regular basis.

On behalf of the Vantage Urologic Institute thank you for your interest in our organization and we look forward to providing all of your urologic health needs.

D. Russell Locke, M.D., FACS
Chairman and Founding Director